We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Aarhus, Denmark (29 November 2021) – Today Cercare Medical announces that it is partnering with Arterys to offer its perfusion imaging clinical application as part of Arterys cloud-based platform. Arterys is the leading global imaging platform that delivers world-class clinical AI products over the internet. Cercare Perfusion is an imaging solution that provides radiologists with fast and reliable perfusion maps for brain pathology assessment. The Cercare Medical application complements the platform’s other neuroradiology offerings.
"As Arterys continues to develop and expand the solutions offered on its Neuro AI platform, we are thrilled to bring Cercare’s AI Perfusion tools to our current and new healthcare systems," said Maya Khalifé, Director of Product Management, Arterys. "The technology and quality that Cercare solutions provide through Arterys Neuro platform will add valuable automation to the clinicians’ workflow, and impact to the patients' lives."
Cercare's technology will supplement Arterys' current offerings, allowing users to assess brain tissue viability with accuracy and speed. "We are proud to work with Arterys and offer our technology on its platform," said Mikkel Bo Hansen, founder and CSO at Cercare Medical. "Everyone benefits from giving healthcare providers access to tools that make assessment easier and more accurate, and the providers can choose the modules most useful to them.”